Alamar: Q3 Earnings Snapshot

FREMONT, Calif. (AP) — FREMONT, Calif. (AP) — Alamar Biosciences Inc. (ALMR) on Tuesday reported a loss of $13.3 million in its third quarter.

On a per-share basis, the Fremont, California-based company said it had a loss of 19 cents.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 22 cents per share.

The biotech company focused on proteomics, the study and measurement of proteins in the body posted revenue of $33.5 million in the period.

Alamar expects full-year revenue in the range of $121 million to $123 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALMR at https://www.zacks.com/ap/ALMR